RESEARCH-USE BIOSIMILAR ANTIBODY
Briakinumab
Monoclonal antibody · IgG1
Briakinumab (ABT-874) is a fully human anti-IL-12/23p40 monoclonal antibody. Briakinumab targets and neutralizes IL-12 and IL-23. Briakinumab can be used for the research of rheumatoid arthritis, inflammatory bowel disease, and multiple sclerosis.
TARGETIL12B
YMonoclonal antibody
CATALOGSC-BS-704
CATALOG NUMBERSC-BS-704
MOLECULAR WEIGHTApprox. 143.86 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Briakinumab (ABT-874) is a fully human anti-IL-12/23p40 monoclonal antibody. Briakinumab targets and neutralizes IL-12 and IL-23. Briakinumab can be used for the research of rheumatoid arthritis, inflammatory bowel disease, and multiple sclerosis.
Briakinumab is a recombinant research-use antibody directed against IL12B.